All it takes is one unnecessary comment during a US Food and Drug Administration (FDA) inspection to create confusion, generate additional document requests, trigger follow-up questions, or draw attention to issues investigators weren’t originally examining, according to regulatory experts.
While companies often spend considerable time preparing documents, training subject matter experts (SMEs), and organizing inspection logistics, one of the most overlooked aspects of inspection readiness is knowing when offering additional information is unnecessary.
The challenge is that many employees feel pressure to demonstrate their expertise, fill awkward silences, or answer questions that fall outside their responsibilities. While those responses are often intended to be helpful, they can introduce unnecessary risk during a facility inspection.
QualityHub Principal Consultant Jeff Caldwell says successful inspection communication requires discipline, preparation, and careful selection of employees who will interact directly with FDA investigators.
“It’s very important that your front-room leads recognize that it’s not their job to help the FDA investigator to inspect the business,” he told QHub Insights.
A so-called inspectional “front room” is a designated area in a company’s facility where FDA investigators carry out the majority of their work while on site. It’s also where the firm’s representatives respond to investigator questions and provide requested information, among other tasks.
A manufacturer’s “employees need to understand that they’re there to help facilitate an effective inspection for the FDA on behalf of their company in a manner that demonstrates honesty, control, and compliance to quality and regulatory requirements. One way to do this is to field questions from investigators and provide accurate, relevant answers,” Caldwell said.
“Make sure you speak to your procedures and speak to the record that’s in front of you, but don’t offer opinions,” he added. “The investigator will ask for your opinion, but that doesn’t mean you should give it, because that’s just a good way for the FDA to go down another audit trail.”
Caldwell noted that effective inspection communication starts long before an investigator arrives at a facility. Manufacturers should identify which employees are likely to interact with investigators and evaluate not only their technical expertise but also their communication skills.
“The people who are the most technically adept are not always the best communicators,” he said. “That’s why it’s vital to identify individuals in your organization who have those all-important communication skills.”
Some people naturally excel at communicating under pressure, while others may require coaching and practice. Caldwell stressed that companies should conduct mock inspections, pinpoint promising communicators, and invest in developing those skills prior to the FDA knocking on the door to inspect.
Coaching Leaders to Answer Only What is Asked
QualityHub’s Caldwell further emphasized that inspection readiness extends beyond preparing documents and SMEs. Companies should also spend time coaching employees, particularly senior leaders, on how to communicate effectively with FDA investigators and avoid volunteering unnecessary information.
As an example, Caldwell recalled working with a senior leader whom he initially viewed as a potential risk during an inspection because of their tendency to give lengthy explanations and unsolicited opinions that may not address the issue at hand.
But “through coaching, we were able to bring them to understand what their unoffered opinions and other comments could do to the company during an inspection,” Caldwell said. “The message was simple: answer the question, and don’t feel the need to answer more than the question that’s being asked.”
He pointed out that executives and other senior personnel often require the most preparation because they’re accustomed to making decisions, representing their departments, and explaining complex issues. While those responsibilities are valuable within the organization, they can also increase the likelihood of providing investigators with more information than necessary.
“These are the people who often may offer too much information and are the ones who are most critical to coach,” Caldwell said.
The same concern can apply to executive leadership, including CEOs, he said. Many chief executives come from commercial, financial, or operational backgrounds rather than quality, but they still play a prominent role during inspections and can significantly influence the course of discussions with investigators, if interviewed. The FDA expects that executive leadership is aware and actively engaged with their company’s Quality Management System.
However, “the CEO often is an ex-marketing person or an ex-finance person, and not a quality expert,” Caldwell said. “They may not know everything about quality, but they do know the impact to the business if they don’t answer an FDA investigator’s question correctly. They can therefore naturally be very nervous if not prepared appropriately.”
The Danger of Saying Too Much
One of the most common communication mistakes occurs when employees answer questions an FDA investigator never asked.
QualityHub Principal Consultant Elisabeth George said investigators frequently ask highly targeted questions focused on a specific process step, record, or section of a document. Rather than limiting their response to that narrow question, employees often launch into lengthy explanations covering the entire process.
“What people always want to do is show how smart they are,” George said.
As a result, employees may begin discussing events that occurred before the issue under review, explain related activities that weren’t requested, or speculate about future actions. In some cases, they may even wander into areas where their understanding is incomplete.
“Don’t do that. Instead, focus on exactly what was asked,” George said.
George emphasized that investigators are fully capable of asking follow-up questions if they need additional information. Offering information that wasn’t requested can create new lines of inquiry that otherwise might never have arisen.
“If they want to ask you the next question, let them ask it, but don’t offer up information on a silver platter if it wasn’t asked for,” she said.
Prepping for Difficult Topics
QualityHub’s Caldwell agreed that inspection participants should remain focused and deliberate in their responses. However, he noted that there can be exceptions when investigators appear confused or headed toward an incorrect conclusion.
“If it becomes clear that the FDA may not fully understand the situation or is drawing conclusions based on incomplete information, companies should consider providing additional context to clarify the issue,” Caldwell said.
He added that manufacturers should anticipate topics that are likely to receive significant scrutiny and prepare for those discussions in advance.
“You can’t predict every question an investigator may ask, but you can prepare for many of them.” – Jeff Caldwell
One strategy is to develop “storyboards” for complex quality events, corrective and preventive actions (CAPAs), failure investigations, or other issues that may require detailed explanations. These storyboards may consist of a handful of slides that walk investigators through a complex issue in a logical, concise manner. For example, rather than trying to explain a complicated CAPA from memory, the company can use prepared materials to present a clear and organized narrative.
Caldwell encourages companies to prepare for inspections by thinking through likely questions in advance and determining how they will respond.
“Ask yourself, ‘If we get this question, how are we going to explain it? What do we want to say? What follow-up questions might come next?’” he said. “You can’t predict every question an investigator may ask, but you can prepare for many of them.”
Such preparation allows manufacturers to remain flexible while still maintaining control over how complicated information is communicated.
Why Silence Makes People Nervous
Another challenge arises when investigators stop talking.
Long pauses often make employees uncomfortable, leading them to fill the silence with additional explanations. QualityHub’s George said that tendency can become problematic during inspections because the extra information frequently extends beyond what the investigator originally requested.
“Silence is the FDA’s best way to get more information that could get a company into hot water,” she said.
George said silence doesn’t necessarily mean investigators are expecting additional commentary. Rather, they may simply be reviewing documents, comparing information against their notes, or considering how a company’s processes align with regulatory requirements.
“What you need to remember is, the reason there’s investigator silence is because they’re trying to think,” she said.
The investigator’s role is to assess compliance with regulatory requirements, while company representatives are responsible for explaining their processes. Both sides sometimes need time to process information before moving forward.
Saying ‘I Don’t Know’ is A-OK
Many employees worry that admitting they don’t know an answer will damage their credibility with FDA investigators, but inspection veterans say the opposite is often true.
QualityHub’s George said employees should avoid speaking outside their area of responsibility and should be comfortable acknowledging when they lack information.
“If an FDA investigator asks a question about something that isn’t your responsibility, you can say, ‘I’m sorry, that’s outside of my responsibility. That’s why I have my team here that are experts. Let me get one of them, because they’re going to be far more intimate with that,’” she said.
Even when a question relates to an employee’s function, there may be legitimate reasons they don’t know the answer. The issue may have occurred before they joined the company, involve a product they don’t directly support, or require information that isn’t immediately available.
“It’s OK to say ‘I don’t know,’” George said.
Meanwhile, QualityHub Principal Consultant Melinda Novatny said effective inspection preparation helps employees understand the types of questions they’re expected to answer. However, inspections frequently evolve into areas that require input from another expert.
“A lot of times during a conversation with an investigator, another angle of a particular topic can come up,” she said. When that happens, employees shouldn’t feel pressured to speculate.
Novatny pointed to interactions on the manufacturing floor as an example. Operators are typically very familiar with their own responsibilities and can recognize when a question falls outside their area of expertise. When that happens, the company host in the front room can help direct the discussion to the appropriate SME.
Experts Novatny and George also caution against answering questions that aren’t fully understood.
Novatny said employees should feel comfortable seeking clarification from investigators when necessary. They can also look to the company’s front-room leader for guidance if they’re uncertain about what’s being asked.
George similarly recommends confirming a question before answering when there is any uncertainty. Clarifying a question demonstrates a desire to provide an accurate answer. Guessing at the investigator’s intent, by contrast, can lead to misunderstandings that can complicate the inspection.
“It’s OK to reflect back the question for the FDA investigator to make sure you understood it correctly,” George said.
Reading the Investigator’s Signals
While companies often focus on the words exchanged during an FDA inspection, experienced front-room leaders also pay close attention to what investigators communicate nonverbally.
According to QualityHub’s Caldwell, one of the front-room lead’s responsibilities is to monitor an investigator’s body language for signs that they may be confused, frustrated, or not receiving the information they need. The challenge, he noted, is that investigators vary widely in how expressive they are.
“Some of them are easy to read, but when it comes to others, it can be extremely difficult,” Caldwell said.
Rather than trying to interpret every gesture, he said the goal is to determine whether the investigator understands the information being presented. If there are noticeable signs of frustration or uncertainty, Caldwell recommends addressing the issue directly through clarifying questions.
“If I start seeing that evidence of frustration that they’re not quite getting what they need, then I’ll ask, ‘Is there something I can clarify for you? Or did I answer your question?’” he said.
Front-room leads can also acknowledge other cues, such as time pressure, by offering assistance and asking whether additional information would be helpful. Caldwell described these responses as part of being attentive to an investigator’s needs and adjusting communication accordingly.
At the same time, he cautioned against overinterpreting body language. Many common gestures can have multiple meanings depending on the individual and the situation. Cultural differences can also influence how people communicate nonverbally. For example, Caldwell noted that while avoiding eye contact is sometimes interpreted in Western cultures as a sign of deception, other cultures may view prolonged eye contact as aggressive.
As a result, he said effective front-room leads combine observation with situational awareness, focusing less on specific gestures and more on whether the investigator appears to be obtaining information they need.
Watch Your Language
Finally, manufacturers should keep in mind that the words employees use can shape an investigator’s perception of the company and its quality culture.
QualityHub’s Novatny cautioned against using dismissive, casual, or inflammatory language that minimizes quality concerns. Even comments intended as jokes can create a negative impression.
“Whatever you do, do not be flippant or minimize any of the FDA’s questions,” Novatny said.
Instead, discussions should remain focused on facts, data, and objective evidence, she said, noting that attempts to brush off concerns can suggest that the company is not taking issues seriously.
Ultimately, the experts agree that inspection communication isn’t about saying as much as possible. Rather, it’s about delivering accurate, focused, and thoughtful answers while remaining within one’s area of expertise. In an environment where every statement can influence an investigator’s understanding, knowing when to stop talking can be just as important as knowing what to say.
